Nobel Committe Under Drug Influence?

  • Thread starter Thread starter George Jones
  • Start date Start date
Click For Summary
SUMMARY

AstraZeneca is currently under criminal investigation for potential influence in the awarding of the latest Nobel Prize in Medicine. The discussion highlights concerns regarding the integrity of the Nobel Prize process, emphasizing that the appearance of impropriety can be as damaging as actual corruption. Participants express skepticism about the effectiveness of existing rules governing academic grants and speaking engagements, suggesting that the investigation's outcomes are crucial for maintaining trust in the scientific community.

PREREQUISITES
  • Understanding of the Nobel Prize selection process
  • Familiarity with pharmaceutical industry practices
  • Knowledge of academic grant funding mechanisms
  • Awareness of ethical standards in medical research
NEXT STEPS
  • Research the Nobel Prize selection criteria and potential reforms
  • Investigate the implications of pharmaceutical influence on medical research
  • Explore ethical guidelines for academic conferences and honoraria
  • Learn about the role of regulatory bodies like the FDA in drug approval processes
USEFUL FOR

This discussion is beneficial for medical researchers, pharmaceutical industry professionals, ethicists, and anyone interested in the intersection of medicine and ethics in award processes.

George Jones
Staff Emeritus
Science Advisor
Gold Member
Messages
7,643
Reaction score
1,602
Pharmaceutical giant AstraZeneca currently is the subject of a criminal investigation for possible influence in the awarding of the most recentl Nobel Prize in medicine.

http://www.thestar.com/news/world/article/555701
 
Physics news on Phys.org
George Jones said:
Pharmaceutical giant AstraZeneca currently is the subject of a criminal investigation for possible influence in the awarding of the most recentl Nobel Prize in medicine.

http://www.thestar.com/news/world/article/555701

I don't know but that it looks a little slim. For something like the Nobel the appearance of impropriety is every bit as damaging as actual corruption. Recognizing that it is a complex world though, and there are lots of grant monies funding any number of academic efforts for all sorts of reasons from philanthropy to self interest, it's seemingly a daunting task to be sure that in such an interconnected world that all recusable associations are ferreted out before any damage is done.

Now taking junkets - if that's what it was - that could be another issue that I'd think they would already have rules about. And if they didn't they should. On the other hand an invitation to speak at a conference with an honorarium that covered expenses could as easily be seen as a junket. So I guess that we will have to see what investigation turns up, and hope that good sense would have prevailed. It would surely be disappointing to me if it turns out otherwise.
 
Would it be worth the effort?
The customer isn't going to buy your aspirin/cold medicene over the other because you have a Nobel winner, the FDA aren't going to be persuaded to license the drug any easier. And if you just wanted bragging rights that MegaPharmaCorp had more Nobel winners than GigaDrugsLLC you just poach a few near-retirees from universites.
 

Similar threads

  • · Replies 1 ·
Replies
1
Views
3K
  • · Replies 19 ·
Replies
19
Views
3K
  • · Replies 7 ·
Replies
7
Views
3K
  • · Replies 2 ·
Replies
2
Views
5K
Replies
1
Views
2K
  • · Replies 2 ·
Replies
2
Views
4K
  • · Replies 7 ·
Replies
7
Views
4K
Replies
4
Views
605
  • · Replies 1 ·
Replies
1
Views
2K
Replies
10
Views
4K